Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Divis Laboratories

Divis Laboratories

BSE: 532488|NSE: DIVISLAB|ISIN: INE361B01024|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 23, 16:00
1049.55
31.3 (3.07%)
VOLUME 34,752
LIVE
NSE
Feb 23, 15:59
1050.10
30.85 (3.03%)
VOLUME 806,228
News on Divis Laboratories
Select Year: 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Divis thinking of relocating proposed Kakinada plant due to land acquisition woes

6.14 pm | 30 Jan 2018 |  Source: Moneycontrol.com

The Rs 700 crore project has been hit by ongoing court cases related to land acquisition, as local farmers refuse to part with their land. Locals also...

Divis to spend Rs 300 crore on expansion plans in 2018

4.35 pm | 30 Jan 2018 |  Source: PTI

The company spent about Rs 400 crore till December last year and will be spending another Rs 300 crore on the expansion programme during the current y...

Buy Mindtree, Raymond, Titan Company; sell NBCC, Reliance Infra: Sudarshan Sukhani 

9.16 am | 30 Jan 2018 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can buy Mindtree, Raymond and Titan Company and can sell NBCC and Reliance Infra....

Buy KPIT Technologies, Colgate Palmolive; sell BEML, India Cements: Sudarshan Sukhani 

10.27 am | 29 Jan 2018 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can buy KPIT Technologies and Colgate Palmolive and can sell BEML and India Cements....

Divis Laboratories to consider December quarter results on January 27, 2018

4.08 pm | 18 Jan 2018 |  Source: Moneycontrol.com

Notice is hereby given that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, the 27th day of January 2018 to consid...

Buy Divis Laboratories; target of Rs 1275: Sharekhan

5.24 pm | 13 Nov 2017 |  Source: Moneycontrol.com

Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 1275 in its research report dated Novembe...

Hold Divi’s Laboratories; target of Rs 1090: ICICI Direct

4.28 pm | 07 Nov 2017 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Divi’s Laboratories with a target price of Rs 1090 in its research report dated November 03, 2017....

Divis Labs Q2 profit seen down 1% on lower operational income and revenue 

6.18 pm | 30 Oct 2017 |  Source: CNBC-TV18

Revenue may decline due to ongoing USFDA import alert and re-inspection in Q2 of Unit 2....

Buy Divi's Laboratories; target of Rs 1080: Axis Direct

5.37 pm | 09 Oct 2017 |  Source: Moneycontrol.com

Axis Direct is bullish on Divi's Laboratories has recommended buy rating on the stock with a target price of Rs 1080 in its research report dated ...

Hold Divi’s Laboratories; target of Rs 1040: Sharekhan

3.33 pm | 26 Sep 2017 |  Source: Moneycontrol.com

Sharekhan is recommended hold rating on Divi’s Laboratories with a target price of Rs 1040 in its research report dated September 20, 2017....

1 2
Quick Links for Divis Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.